Addex Therapeutics Ltd logo
Addex Therapeutics Ltd ADXN
$ 7.9 0.51%

Annual report 2023
added 12-21-2024

report update icon

Addex Therapeutics Ltd Financial Statements 2011-2024 | ADXN

Annual Financial Statements Addex Therapeutics Ltd

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- - 196 M 47.4 M 24 M - - - - - - - -

Shares

- - 34.1 M 4.4 M 4.4 M - - - - - - - -

Historical Prices

16.1 0.52 5.73 10.8 - - - - - - - - -

Net Income

- - -15.4 M -12.9 M -14.8 M -1.64 M -3.28 M -3.15 M -4.2 M -1.77 M -14.5 M -27 M -31.1 M

Revenue

- - - 3.61 M 2.76 M 6.04 M - - - - - - 2.82 M

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - 2.53 M 5.9 M -29.8 K - - - - -1.27 M -25.2 M

Operating Income

- - -15.5 M -12.2 M -14.6 M -1.42 M -3.24 M - - - - - -

Interest Expense

1.64 K 25.9 K 39.1 K 50.5 K 106 K 134 K 171 - - - - - -

EBITDA

- - -15.5 M -12.2 M -14.6 M -1.42 M -3.24 M -3.12 M -2.61 M -1.71 M -13.8 M -24.9 M -28 M

Operating Expenses

11.9 M 22 M 18.7 M 16.1 M 17.4 M 8.13 M 3.73 M - - - - 25.7 M 5.81 M

General and Administrative Expenses

- - 5.82 M 5.15 M 4.92 M 4.72 M 2.2 M 1.52 M 1.57 M 1.55 M 6.47 M 12.9 M 6.73 M

All numbers in CHF currency

Quarterly Income Statement Addex Therapeutics Ltd

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in CHF currency